2024-11-05 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis Report

**1. Performance vs. S&P 500:**

* **Company Overview:** Abbott Laboratories is a global healthcare company that develops, manufactures, and sells a wide range of medical devices, pharmaceuticals, and nutrition products.
* **Cumulative Returns:**
    * **ABT:** 110.13%
    * **VOO (S&P 500):** 131.28%
* **Performance Gap:** ABT has underperformed the S&P 500 by **-21.15%**. The current relative performance is at the 19.6th percentile, indicating that ABT's performance has been below the S&P 500 for most of its history.

* **Alpha & Beta Analysis:**
    * **Alpha:** The stock has generally outperformed the market (positive alpha) except in 2016, 2019, and 2023.
    * **Beta:** ABT's beta is mostly above 1, indicating a higher volatility than the market. However, it has decreased in recent years, suggesting a lower sensitivity to market swings.

**2. Recent Price Action:**

* **Closing Price:** $117.65 (Last-market: $117.67)
* **Moving Averages:**
    * **5-day:** $115.49
    * **20-day:** $116.16
    * **60-day:** $114.30

* **Analysis:** The stock price is currently trading above its 5-day, 20-day, and 60-day moving averages, suggesting an upward trend. However, the recent closing price is very close to the Last-market price, indicating a possible consolidation phase or potential correction.

**3. Technical Indicators:**

* **RSI:** 54.12 (Neutral) - The RSI indicates a neutral momentum for the stock, neither overbought nor oversold.
* **PPO:** -0.01 (Slightly Bearish) - The PPO suggests a slight bearish trend.
* **Delta_Previous_Relative_Divergence:** 5.39 (+): This indicates short-term bullish momentum.
* **Expected Return:** 0.0% - This implies that the stock is expected to perform in line with the S&P 500 in the long run (2+ years) for a long-term investor. 

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-31 | 0.94 | $10.63 B |
| 2024-07-31 | 0.74 | $10.38 B |
| 2024-05-02 | 0.7 | $9.96 B |
| 2023-11-01 | 0.82 | $10.14 B |
| 2024-10-31 | 0.82 | $10.14 B |

* **Analysis:**  ABT has consistently delivered strong revenue growth, exceeding analysts' expectations in recent quarters. However, the EPS for the most recent quarter (2024-10-31) was slightly lower than expected. 

**5. Financial Information:**

* **Revenue and Profitability:**
    * Strong revenue growth and consistent profitability with a high profit margin.
* **Capital and Profitability:**
    * Healthy equity levels with a stable ROE, indicating good management of capital and efficient operations.

**6. News and Recent Issues:**

* **Recent Earnings News:** According to Shacknews, ABT's recent earnings report was well-received by investors, exceeding revenue estimates but falling short on earnings per share.  
* **Recent Market Outlook:** Finbold reports a mixed outlook for ABT, with analysts citing its strong business fundamentals and global reach as positive factors, while also noting potential challenges from competition and regulatory scrutiny.

**7. Analyst Opinions and Performance Highlights:**

* **Analyst Opinions:** Most analysts rate ABT as a **"Hold"** or **"Buy"**, highlighting its consistent dividend payouts, robust cash flow generation, and growth opportunities in emerging markets. 
* **Performance Highlights:** ABT's share price has been relatively stable in the past year, with a steady upward trend, indicating investor confidence in its long-term prospects. 

**8. Overall Analysis:**

ABT exhibits a solid financial performance, stable profitability, and strong revenue growth. It demonstrates a robust business model with consistent dividend payouts. Although it has underperformed the S&P 500 in recent years, its recent earnings report and favorable analyst opinions suggest potential for future growth. However, the stock's current price action and slight bearish PPO signal a potential consolidation phase or correction. 

**9. Recommendations:**

* Long-term investors seeking a steady income stream and exposure to the healthcare sector may consider ABT for its consistent dividend payouts and solid business fundamentals.
* Short-term investors may want to wait for a potential correction or a clear sign of a new upward trend before entering a position.
* It is important to monitor market conditions and news announcements to make informed decisions.

**Disclaimer:** This report is for informational purposes only and should not be considered as investment advice. The information provided is based on publicly available data and does not constitute a recommendation to buy or sell any securities.  
